Among these, BICD1, CEP55, COL4A1, SCAMP4, SIPA1L3, SLC35F2, TCF20, and TMCC1 were upregulated in tumor samples, while APBB1IP, APBB2, BANK1, CHRM3, CIITA, COLEC12, ENTPD1, FBXL7, GLI2, HLA-DQB1, KLF12, KLK3, LYZ, MBP, NRP2, RBMS3, ROBO1, SDK2, TRAT1, and ULK2 were downregulated. This evidence concerns the gene CHRM3 and neoplasm.